Psoriasis-Targets and Therapy

Scope & Guideline

Connecting researchers to elevate psoriasis care globally.

Introduction

Explore the comprehensive scope of Psoriasis-Targets and Therapy through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Psoriasis-Targets and Therapy in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN-
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationPSORIASIS-TARGETS TH / Psoriasis-Targets Ther
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The journal "Psoriasis-Targets and Therapy" is dedicated to advancing the understanding and management of psoriasis and related conditions through rigorous research and clinical insights. Its scope encompasses a wide range of topics related to the pathophysiology, treatment, and psychosocial aspects of psoriasis.
  1. Clinical Management of Psoriasis:
    Focuses on the latest therapeutic strategies, including biologics, systemic therapies, and topical treatments, aimed at improving patient outcomes.
  2. Comorbidities and Psoriasis:
    Explores the relationship between psoriasis and various comorbid conditions, such as metabolic syndrome, cardiovascular diseases, and psychological impacts.
  3. Innovative Therapies and Drug Development:
    Highlights emerging therapies, including novel biologics and precision medicine approaches, contributing to the evolving landscape of psoriasis treatment.
  4. Real-World Evidence and Patient Experiences:
    Emphasizes studies that provide insights into the effectiveness, safety, and patient perceptions of psoriasis treatments in everyday clinical settings.
  5. Public Health and Epidemiology:
    Examines the epidemiological aspects of psoriasis, including risk factors, burden of disease, and healthcare resource utilization.
Recent publications in "Psoriasis-Targets and Therapy" indicate a shift towards several emerging themes that reflect current trends in psoriasis research and treatment.
  1. Impact of Lifestyle and Environmental Factors:
    Increasing attention is being paid to how lifestyle choices, such as diet and smoking, as well as environmental factors, influence psoriasis severity and treatment outcomes.
  2. Psychosocial Aspects of Psoriasis:
    Emerging research is focusing on the psychological well-being of psoriasis patients, including the impact of the disease on quality of life and the importance of mental health support.
  3. COVID-19 and Psoriasis Management:
    The ongoing pandemic has led to a surge in research examining the implications of COVID-19 for psoriasis patients, particularly regarding vaccine safety and disease management during the pandemic.
  4. Precision Medicine in Psoriasis Treatment:
    There is a growing interest in personalized medicine approaches, tailoring treatment strategies based on individual patient profiles, comorbidities, and genetic factors.
  5. Telemedicine in Dermatology:
    The rise of telehealth solutions has been a significant trend, with studies exploring the effectiveness of telemedicine in managing psoriasis and improving patient access to care.

Declining or Waning

As the field of psoriasis research evolves, certain themes have become less prominent in recent publications. These waning scopes indicate a shift in focus towards more pressing issues and innovative approaches.
  1. Traditional Topical Treatments:
    While still relevant, there has been a noticeable decline in studies focused on conventional topical treatments as attention shifts towards systemic therapies and biologics.
  2. Pediatric Psoriasis:
    Research on pediatric psoriasis is becoming less frequent, possibly due to a growing emphasis on adult populations and their specific treatment challenges.
  3. Basic Pathophysiology Studies:
    Basic science research that solely focuses on the fundamental mechanisms of psoriasis has seen reduced publication rates, as there is a greater interest in translational research that bridges basic science with clinical applications.

Similar Journals

Clinical Genitourinary Cancer

Exploring breakthroughs in cancer treatment and management.
Publisher: CIG MEDIA GROUP, LPISSN: 1558-7673Frequency: 6 issues/year

Clinical Genitourinary Cancer, published by CIG MEDIA GROUP, LP, is a leading journal in the fields of Oncology and Urology, with an impressive impact reflected in its quartile rankings (Q2 in Oncology and Q1 in Urology for 2023) and strong Scopus rankings (22nd in Urology and 162nd in Oncology). The journal aims to innovate and inspire new research in genitourinary malignancies, providing a platform for the latest findings in diagnosis, treatment, and patient management. With its commitment to high-quality publications since its establishment in 2005, Clinical Genitourinary Cancer serves a crucial role in advancing the understanding of these complex conditions and enhancing clinical practices. Researchers, professionals, and students in the medical community are encouraged to engage with this essential resource, which facilitates open access to pioneering studies that drive the field forward.

Pediatric Rheumatology

Exploring the forefront of child health and rheumatology.
Publisher: BMCISSN: Frequency: 1 issue/year

Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.

Annals of Dermatology

Pioneering insights into skin health and disease.
Publisher: KOREAN DERMATOLOGICAL ASSOCISSN: 1013-9087Frequency: 6 issues/year

Annals of Dermatology is a prestigious academic journal published by the Korean Dermatological Association, focusing on the latest research and advancements in the field of dermatology. With a commitment to advancing knowledge in skin health and disease, this journal serves as a vital resource for researchers, clinicians, and students working in dermatology and related disciplines. Since its inception in 1989, it has evolved to consolidate its position in the academic community, boasting a Q2 ranking in the 2023 Dermatology category and a Scopus rank of #87 out of 142, placing it in the 39th percentile. Although it operates under a subscription model, the journal's impact factor reflects its significance in advancing dermatological research, attracting innovative studies and reviews that shape clinical practice. With a publication history extending from 1989 to 1996 and then from 2008 to the present, Annals of Dermatology continues to be an essential publication for those devoted to improving skin health.

AKTUELLE RHEUMATOLOGIE

Exploring innovative solutions for rheumatic diseases.
Publisher: GEORG THIEME VERLAG KGISSN: 0341-051XFrequency: 6 issues/year

AKTUELLE RHEUMATOLOGIE is a prominent German journal published by GEORG THIEME VERLAG KG, dedicated to advancing the field of rheumatology. Since its inception in 1978, this peer-reviewed journal has been a vital resource for professionals, researchers, and students engaged in the study and treatment of rheumatic diseases. With an ISSN of 0341-051X and an E-ISSN of 1438-9940, the journal provides a platform for sharing groundbreaking research, clinical studies, and reviews. Although classified in the fourth quartile (Q4) of rheumatology journals and ranked 67 out of 73 in its category according to Scopus, AKTUELLE RHEUMATOLOGIE continues to contribute to the discourse in rheumatology. Its comprehensive coverage of recent advancements and innovative approaches makes it an essential publication for anyone interested in the latest developments in the field.

Hepatic Oncology

Elevating Research on Hepatic Malignancies
Publisher: FUTURE MEDICINE LTDISSN: 2045-0923Frequency: 4 issues/year

Hepatic Oncology is a premier Open Access journal published by Future Medicine Ltd that specializes in the critical intersection of hepatology and oncology. With a focus on advancing knowledge in the diagnosis and treatment of liver cancers, the journal provides a platform for innovative research, reviews, and clinical perspectives that serve as a valuable resource for researchers, clinicians, and students alike. Established in 2016 and evolving over the years, Hepatic Oncology underscores its commitment to accessible scientific communication, having transitioned to open access in 2018 to reach a broader audience. The journal holds a Q4 quartile ranking in the fields of hepatology and oncology for 2023, reflecting its emerging influence and role in contemporary research. Through high-quality articles and a focus on real-world applications, Hepatic Oncology aims to bridge gaps in knowledge while fostering collaboration among professionals dedicated to enhancing patient care in hepatic malignancies.

JOURNAL OF DERMATOLOGICAL TREATMENT

Elevating standards in skin treatment and care.
Publisher: TAYLOR & FRANCIS LTDISSN: 0954-6634Frequency: 8 issues/year

The JOURNAL OF DERMATOLOGICAL TREATMENT, published by TAYLOR & FRANCIS LTD, is a premier forum dedicated to advancing the field of dermatology through the dissemination of high-quality research. Since its inception in 1989, this journal has maintained a significant impact on the dermatological community, currently ranking in the top quartile (Q1) of the Dermatology category with an impressive Scopus ranking of #14 out of 142 journals, reflecting its reputation among peers and its contribution to the clinical and academic landscape. The journal shifted to Open Access in 2023, enhancing the accessibility of groundbreaking findings to researchers, clinicians, and students worldwide. With a commitment to publishing diverse articles, from innovative treatment modalities to comprehensive reviews, the JOURNAL OF DERMATOLOGICAL TREATMENT serves as an invaluable resource for professionals seeking to stay at the forefront of dermatological science in a rapidly evolving field.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Innovating Treatment Strategies for Every Condition
Publisher: ADIS INT LTDISSN: 1175-0561Frequency: 6 issues/year

The American Journal of Clinical Dermatology, published by Adis International Ltd, is a leading peer-reviewed journal dedicated to advancing the field of dermatology. With a notable impact factor and a prestigious Q1 rank in both Dermatology and Miscellaneous Medicine categories, this journal stands out as a valuable resource for researchers and clinicians alike, offering cutting-edge insights into clinical practice and innovative treatment strategies. Its comprehensive scope encompasses a broad range of topics within dermatology, addressing both common and rare conditions, with a focus on emerging therapies and technologies. As it converges its publication years from 2000 to 2024, the journal remains an essential platform for disseminating high-quality research to professionals striving to improve patient care and outcomes. With the ISSN 1175-0561 and E-ISSN 1179-1888, the American Journal of Clinical Dermatology facilitates greater accessibility to pivotal findings within the field, making it an indispensable resource for anyone involved in dermatological research and practice.

Dermatology and Therapy

Exploring breakthroughs in skin health and treatment.
Publisher: ADIS INT LTDISSN: 2193-8210Frequency: 12 issues/year

Dermatology and Therapy is a prestigious Open Access journal, published by ADIS INT LTD since 2011, that has quickly established itself as a vital resource in the field of dermatology. With an impressive Q1 ranking in the Dermatology category as of 2023 and a commitment to disseminating high-quality research, this journal fosters innovation and knowledge exchange among professionals, researchers, and students alike. Its broad scope encompasses the latest advancements in dermatological therapies, contributing significantly to both clinical practice and academic research. Based in Germany and operating under a global perspective, Dermatology and Therapy provides an essential platform for open access research, encouraging unrestricted access to groundbreaking studies and fostering collaboration across borders. Join the community of dermatology experts by exploring the wealth of knowledge available in this influential journal.

Cancer Management and Research

Empowering healthcare professionals with cutting-edge findings.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-1322Frequency: 1 issue/year

Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.

Reumatismo

Empowering healthcare through innovative rheumatology insights.
Publisher: PAGEPRESS PUBLISSN: 0048-7449Frequency: 4 issues/year

Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.